Mature DCs enhance uptake of tumor-associated antigens (TAAs) and subsequent cross-presentation with CD8+ CTLs, thereby initiating a tumor-specific adaptive immune response, activating T cells and forming memory phenotypes (181–183). Here, CD8A is linked to neoplasm.